rxstat › Shortages › Rasagiline

Rasagiline shortage status

Widespread shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Rasagiline is in a widespread shortage in Canada. 4 of 7 reported products are affected. The latest manufacturer estimate for full recovery is Jul 31, 2026.
Products affected
4 / 7
In shortage since
Oct 8, 2025
Est. full return
Jul 31, 2026
Reports on file
35
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.

Reports by product

Active shortage
TEVA-RASAGILINE
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02418436 · since Jan 21, 2026, est. end Jul 20, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP RASAGILINE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491974 · since Mar 12, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP RASAGILINE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491982 · since Apr 21, 2026, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP RASAGILINE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491982 · since Oct 31, 2025, est. end Jul 31, 2026 · Disruption of the manufacture of the drug.
Active shortage
APO-RASAGILINE
1MG · TABLET · APOTEX INC
DIN 02404699 · since Oct 8, 2025, est. end Apr 17, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP RASAGILINE
1MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491982 · ended Jan 23, 2026 · Disruption of the manufacture of the drug.
Resolved
JAMP RASAGILINE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491974 · ended Jan 23, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-RASAGILINE
0.5MG · TABLET · TEVA CANADA LIMITED
DIN 02418436 · ended Jan 7, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-RASAGILINE
1MG · TABLET · TEVA CANADA LIMITED
DIN 02418444 · ended Sep 23, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP RASAGILINE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491974 · ended Jul 15, 2025 · Disruption of the manufacture of the drug.
Resolved
JAMP RASAGILINE
0.5MG · TABLET · JAMP PHARMA CORPORATION
DIN 02491974 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
reversed
TEVA-RASAGILINE
1MG · TABLET · TEVA CANADA LIMITED
DIN 02418444

Showing 12 of 35 reports. All reports are on file with Health Canada.

What's happening

Rasagiline is currently affected by 4 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, JAMP PHARMA CORPORATION, APOTEX INC.

The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.

If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.

Rasagiline is classified under “DOPAMINERGIC AGENTS” (ATC N04BD).

Recent changes

Common questions

When will Rasagiline be back in stock in Canada?

The latest manufacturer estimate is Jul 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.

Why is Rasagiline in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (dopaminergic agents)

Partial shortageApomorphine1 of 6 reported products affectedPartial shortageCarbidopa Levodopa4 of 21 reported products affected · est. return Nov 30, 2026Partial shortageEntacapone1 of 4 reported products affected · est. return Jul 20, 2026Partial shortagePramipexole Dihydrochloride4 of 40 reported products affected · est. return Sep 4, 2026Partial shortageRopinirole5 of 23 reported products affected · est. return Aug 10, 2026Partial shortageSelegiline1 of 3 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.